Cargando…

Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study

BACKGROUND: Chronic inflammatory diseases (CIDs; ankylosing spondylitis [AS], psoriatic arthritis [PsA], psoriasis [PsO], or rheumatoid arthritis [RA]) and inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis) are associated with substantial economic burden. The relative increased...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hudesman, David P., Chakravarty, Soumya D., Emond, Bruno, Ellis, Lorie A., Lefebvre, Patrick, Sadik, Kay, Scher, Jose U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114816/ https://www.ncbi.nlm.nih.gov/pubmed/32266326 http://dx.doi.org/10.1186/s41927-020-0115-2

Ejemplares similares

Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease
por: Bogale, Kaleb, et al.
Publicado: (2022)

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis
por: Vanderpoel, Julie, et al.
Publicado: (2023)

Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
por: Jung, Yoon Suk
Publicado: (2020)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

Costs in inflammatory bowel diseases
por: Petryszyn, Paweł W., et al.
Publicado: (2016)

All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease
por: Stein, Daniel J.
Publicado: (2020)

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
por: Haberman, Rebecca, et al.
Publicado: (2020)

Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
por: Setyawan, Juliana, et al.
Publicado: (2021)

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil
por: Parra, Rogerio S, et al.
Publicado: (2019)

The cost of illness analysis of inflammatory bowel disease
por: Pakdin, Majid, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore
por: Yeo, Jia Qi, et al.
Publicado: (2022)

Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA
por: Ungaro, Ryan C, et al.
Publicado: (2022)

Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease
por: Kavcar, Zubeyr, et al.
Publicado: (2023)

Burden of Disease and Cost of Illness of Inflammatory Bowel Diseases in Portugal
por: Magro, Fernando, et al.
Publicado: (2022)

Race and Inflammatory Bowel Disease in an Urban Healthcare System
por: Sewell, Justin L., et al.
Publicado: (2010)

Patient-reported healthcare expectations in inflammatory bowel diseases
por: Pittet, Valérie, et al.
Publicado: (2018)

Healthcare maintenance in elderly patients with inflammatory bowel disease
por: Shrestha, Manish P., et al.
Publicado: (2017)

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
por: Rampakakis, Emmanouil, et al.
Publicado: (2019)

Parental inflammatory bowel disease and autism in children
por: Sadik, Aws, et al.
Publicado: (2022)

Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
por: Emond, Bruno, et al.
Publicado: (2018)

Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data
por: Long, Gráinne H., et al.
Publicado: (2019)

Inflammatory Bowel Disease Education: I Can Hear the Extension for Community Healthcare Outcomes
por: Boynton, Kathleen, et al.
Publicado: (2015)

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
por: Martins, Camilla de Almeida, et al.
Publicado: (2022)

Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK
por: Kapasi, Rukshana, et al.
Publicado: (2019)

Cytomegalovirus-Related Hospitalization Is Associated With Adverse Outcomes and Increased Health-Care Resource Utilization in Inflammatory Bowel Disease
por: Zhang, Cheng, et al.
Publicado: (2016)

Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease
por: Stone, Katherine L., et al.
Publicado: (2023)

Inflammatory bowel disease /
Publicado: (2000)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Inflammatory Bowel Disease
por: Lee, Shona J., et al.
Publicado: (2014)

Inflammatory Bowel Disease
por: Nasseri-Moghaddam, Siavosh
Publicado: (2012)

Inflammatory Bowel Disease
Publicado: (2013)

INFLAMMATORY BOWEL DISEASE
por: Johns, Alice J.
Publicado: (2001)

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases
por: Axelrad, Jordan E., et al.
Publicado: (2019)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
por: Blanchette, Christopher M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fh8jb6rk9q5kbtgren86gaj71e